Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Drugsmarket, defines the market attractiveness level of Oncology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Drugs industry, describes the types of Oncology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Drugs market and the development prospects and opportunities of Oncology Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Drugs market in Chapter 13.
By Player:
GuiZhou YiBai
Lunan
Roche
QILU
Sanofi
Novartis
Eli Lilly and Company
LUYE
AstraZeneca
HENGRUI
HANSOH
By Type:
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
By End-User:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Drugs Market Analysis and Outlook to 2022
-
7.1 Global Oncology Drugs Consumption (2017-2022)
-
7.2 United States Oncology Drugs Consumption (2017-2022)
-
7.3 Europe Oncology Drugs Consumption (2017-2022)
-
7.4 China Oncology Drugs Consumption (2017-2022)
-
7.5 Japan Oncology Drugs Consumption (2017-2022)
-
7.6 India Oncology Drugs Consumption (2017-2022)
-
7.7 South Korea Oncology Drugs Consumption (2017-2022)
8 Region and Country-wise Oncology Drugs Market Analysis and Outlook to 2028
-
8.1 Global Oncology Drugs Consumption Forecast (2022-2028)
-
8.2 United States Oncology Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Drugs Consumption Forecast (2022-2028)
-
8.4 China Oncology Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Drugs Consumption Forecast (2022-2028)
-
8.6 India Oncology Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Drugs Consumption Forecast (2022-2028)
9 Global Oncology Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antimetabolite Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alkaloid drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted drug Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Platinum-based drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Global Oncology Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antimetabolite Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alkaloid drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Platinum-based drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Drugs Market Competitive Analysis
-
14.1 GuiZhou YiBai
-
14.1.1 GuiZhou YiBai Company Details
-
14.1.2 GuiZhou YiBai Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GuiZhou YiBai Oncology Drugs Product and Service
-
14.2 Lunan
-
14.2.1 Lunan Company Details
-
14.2.2 Lunan Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Lunan Oncology Drugs Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Oncology Drugs Product and Service
-
14.4 QILU
-
14.4.1 QILU Company Details
-
14.4.2 QILU Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 QILU Oncology Drugs Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Oncology Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Oncology Drugs Product and Service
-
14.7 Eli Lilly and Company
-
14.7.1 Eli Lilly and Company Company Details
-
14.7.2 Eli Lilly and Company Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly and Company Oncology Drugs Product and Service
-
14.8 LUYE
-
14.8.1 LUYE Company Details
-
14.8.2 LUYE Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 LUYE Oncology Drugs Product and Service
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Details
-
14.9.2 AstraZeneca Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Oncology Drugs Product and Service
-
14.10 HENGRUI
-
14.10.1 HENGRUI Company Details
-
14.10.2 HENGRUI Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 HENGRUI Oncology Drugs Product and Service
-
14.11 HANSOH
-
14.11.1 HANSOH Company Details
-
14.11.2 HANSOH Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 HANSOH Oncology Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Drugs
-
Figure Oncology Drugs Picture
-
Table Global Oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Drugs Consumption by Country (2017-2022)
-
Figure United States Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antimetabolite Consumption and Growth Rate (2017-2022)
-
Figure Global Alkaloid drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted drug Consumption and Growth Rate (2017-2022)
-
Figure Global Platinum-based drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Antimetabolite Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alkaloid drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Platinum-based drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table GuiZhou YiBai (Foundation Year, Company Profile and etc.)
-
Table GuiZhou YiBai Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GuiZhou YiBai Oncology Drugs Product and Service
-
Table Lunan (Foundation Year, Company Profile and etc.)
-
Table Lunan Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lunan Oncology Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Oncology Drugs Product and Service
-
Table QILU (Foundation Year, Company Profile and etc.)
-
Table QILU Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table QILU Oncology Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oncology Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oncology Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Oncology Drugs Product and Service
-
Table LUYE (Foundation Year, Company Profile and etc.)
-
Table LUYE Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table LUYE Oncology Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oncology Drugs Product and Service
-
Table HENGRUI (Foundation Year, Company Profile and etc.)
-
Table HENGRUI Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HENGRUI Oncology Drugs Product and Service
-
Table HANSOH (Foundation Year, Company Profile and etc.)
-
Table HANSOH Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HANSOH Oncology Drugs Product and Service
-
